Nanotechnology Now - Press Release: "Nanomedicine Coverage at Cientifica: Full Sector Coverage from Diagnostics to Drug Delivery Systems"

Home > Press > Nanomedicine Coverage at Cientifica: Full Sector Coverage from Diagnostics to Drug Delivery Systems

Abstract:
The healthcare market is poised to see some of the earliest benefits of nanotechnology. Over the next decade, it will be one of nanotech's highest growth sectors and Cientifica provides in depth coverage of the key technologies and their impact.

Nanomedicine Coverage at Cientifica: Full Sector Coverage from Diagnostics to Drug Delivery Systems

London, UK | Posted on April 2nd, 2012

Targeted drug delivery therapies for the treatment of cancer is one of the most commonly cited nano-healthcare benefits. Cientifica's report, Nanotechnology for Drug Delivery, gives a comprehensive analysis and geographic breakdown of the current nanotechnology drug delivery market and its most relevant technologies. It also provides a forecast for the size of total addressable markets and percent share of those key technologies to 2021.

Nanotech enabled medical diagnostics promise to improve just about everything that can be improved from a diagnostics point of view: earlier detection of disease, higher sensitivity, higher accuracy, higher throughput capability, more results per assay; time saving and cost-effectiveness.

Since we now know most (if not all) biological processes occur at the nanoscale, the application of life science principles - studying the causes of biological phenomena at the molecular level - means medical and biomedical research is increasingly using a bottom-up (rather than the top-down) approach. The low bioavailability resulting from traditional oral and intravenous drug delivery methods and the market forces at work in the pharmaceutical industry, where patents expire after a relatively short period of time unless a novel form of drug delivery is developed that will extend the patent, are two major forces that will fuel the growth of the nanotech drug delivery market. The third factor at play is a combination of improved global health and a correspondingly dramatic increase in the size of the global aging population.

Our studies and reports provide insight into targeted nanotech drug delivery, medical diagnostics and their market potential over the next decade.

####

About Cientifica Ltd.
We help businesses by advising on strategic and sustainable growth and helping them to diversify their products and markets by harnessing emerging technologies. We do this by scouting the emerging technology landscape whilst keeping abreast with key issues such as sustainable manufacturing and resource management through our close links to the World Economic Forum and many others. Clients who work with us are thus able to diversify their business through entry into new markets whilst understanding how to minimise their environmental impact.

Our broad range of expertise, knowledge and contacts means we are uniquely placed to understand and advise on the complexities, opportunities and pitfalls associated with adopting and commercialising emerging technologies in your business. Our core team is made up of scientists and investment professionals. But when necessary, we are able to tap an envious talent pool of specialised skill sets from our global networks in government, science and finance to ensure we deliver a bespoke solution that is right for you.

For more information, please click here

Contacts:
4 The Grove
Ilkley, West Yorlshire LS29 9EG, UK
+44 7894 708989

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: